Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Mutation, Gene Flow, and Genetic Drift

Mutation, Gene Flow, and Genetic Drift

In a population that is not at Hardy-Weinberg equilibrium, the frequency of alleles changes over time. Therefore, any deviations from the five conditions of Hardy-Weinberg equilibrium can alter the genetic variation of a given population. Conditions that change the genetic variability of a population include mutations, natural selection, non-random mating, gene flow, and genetic drift (small population size).

Mutations

Mutations

Mutations

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...

Viral Mutations

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...

Gene Therapy

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...

Gene Flow

Gene Flow

Gene flow is the transfer of genes among populations, resulting from either the dispersal of gametes or from the migration of individuals.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Origins of Atlantic Salmon (<i>Salmo salar</i>) Determined Using a Hybridization Assay of Mitochondrial DNA on a Microfluidic Biochip.

Biosensors·2026

Same author

Real-Time Single-Cell Measurement and Kinetic Modeling of Daunorubicin Uptake in Multidrug-Resistant Leukemia Cells Using a Microfluidic Biochip.

Pathophysiology : the official journal of the International Society for Pathophysiology·2026

Same author

Reversal Effects of 20(R)- and 20(S)-Ginsenoside-Rg3 on Daunorubicin Uptake in Multidrug-Resistant Leukemia Cells Studied in the Single-Cell Biochip.

International journal of molecular sciences·2026

Same author

Nanogold-Lateral Flow Assay for Ginseng DNA Differentiation.

Biosensors·2025

Same author

Next-generation DNA sequencing of Panax samples revealed new genotypes: Burrows-Wheeler Aligner, Python-based abundance and clustering analysis.

Heliyon·2024

Same author

Nucleic acid amplification test (NAAT) conducted in a microfluidic chip to differentiate between various ginseng species.

The Analyst·2023

Same journal

Precision Proteomic Profiling of Systemic Lupus Erythematosus-Correlating Disease Activity and Complement Levels with Clinical Phenotypes.

Biomedicines·2026

Same journal

The Role of Salivary Microbiota in Pancreatic Cancer: From Screening to Tumor Progression and Treatment Response.

Biomedicines·2026

Same journal

Diagnostic Utility of Surface Electromyography for Identifying Muscles Affected by Myofascial Trigger Points: A Scoping Review.

Biomedicines·2026

Same journal

Performance Assessment of a Locally Semi-Automated NGS-Based Workflow for Homologous Recombination Deficiency Testing in High-Grade Serous Ovarian Carcinoma.

Biomedicines·2026

Same journal

Coupling and Uncoupling Pleiotropy Between Hypertension and Type 2 Diabetes Contribute to Exploring Potential Heterogeneity in Cardiovascular Risk in East Asian Population.

Biomedicines·2026

Same journal

Maternal Response to Therapeutic Plasma Exchange in Early Gestation: A Case Series of Thrombotic Microangiopathies and Neurological Disorders.

Biomedicines·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jan 29, 2026

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

Detecting EGFR Gene Mutations on a Nanobioarray Chip.

Fang Xu¹, Montek Boparai¹, Christopher Oberc¹

¹Department of Chemistry, Simon Fraser University, Burnaby, BC V5A 1S6, Canada.

|January 28, 2026

Summary

This summary is machine-generated.

A new method detects EGFR mutations for lung cancer therapy. This gold nanoparticle-assisted technique differentiates drug-sensitive and drug-resistant non-small cell lung cancer (NSCLC) mutations, aiding treatment decisions.

Keywords:

DNA hybridization fluorescence detection gene mutation gold nanoparticle wash lung cancer

More Related Videos

Detection of Rare Mutations in CtDNA Using Next Generation Sequencing

Detection of Rare Mutations in CtDNA Using Next Generation Sequencing

Published on: August 24, 2017

The Lambda Select cII Mutation Detection System

The Lambda Select cII Mutation Detection System

Published on: April 26, 2018

Related Experiment Videos

Last Updated: Jan 29, 2026

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

Detection of Rare Mutations in CtDNA Using Next Generation Sequencing

Detection of Rare Mutations in CtDNA Using Next Generation Sequencing

Published on: August 24, 2017

The Lambda Select cII Mutation Detection System

The Lambda Select cII Mutation Detection System

Published on: April 26, 2018

Area of Science:

Biochemistry
Molecular Biology
Genetics

Background:

Epidermal Growth Factor Receptor (EGFR) mutations are key targets in non-small cell lung cancer (NSCLC) therapy.
Tyrosine Kinase Inhibitors (TKIs) are used to treat NSCLC, with efficacy dependent on specific EGFR mutations.
Exon 21 mutations (L858R, L861Q) are TKI-sensitive, while Exon 20 (T790M) mutations confer TKI resistance.

Purpose of the Study:

To develop a rapid detection method for classifying NSCLC patients based on EGFR mutation status.
To differentiate between TKI-sensitive and TKI-resistant EGFR mutations for personalized therapy.

Main Methods:

Design of DNA probes for detecting three specific EGFR point mutations (T790M, L858R, L861Q).
Utilizing a 16-channel nanobioarray chip for single nucleotide polymorphism (SNP) detection via DNA hybridization.
Employing a gold nanoparticle (AuNP)-assisted wash step to enhance differentiation.

Main Results:

Successful differentiation between wild-type (WT) and mutated EGFR sequences.
Enhanced discrimination of TKI-sensitive (L858R, L861Q) and TKI-resistant (T790M) mutations.
Demonstrated efficacy of the AuNP-assisted wash in improving detection accuracy.

Conclusions:

The developed nanobioarray method reliably differentiates WT and key EGFR mutations (T790M, L858R, L861Q) in genomic samples.
This method provides a foundation for rapid clinical classification of NSCLC patients.
Facilitates informed treatment decisions based on EGFR mutation profiles for improved therapeutic outcomes.